Bessemer Group Inc. decreased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5.0% during the second quarter, Holdings Channel reports. The institutional investor owned 40,172 shares of the medical instruments supplier’s stock after selling 2,118 shares during the period. Bessemer Group Inc.’s holdings in DENTSPLY SIRONA were worth $2,604,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Teachers Advisors LLC raised its position in DENTSPLY SIRONA by 18.5% in the fourth quarter. Teachers Advisors LLC now owns 323,176 shares of the medical instruments supplier’s stock valued at $18,657,000 after buying an additional 50,432 shares in the last quarter. Chevy Chase Trust Holdings Inc. raised its position in DENTSPLY SIRONA by 1.5% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 202,398 shares of the medical instruments supplier’s stock valued at $12,638,000 after buying an additional 2,992 shares in the last quarter. Fulton Bank N.A. raised its position in DENTSPLY SIRONA by 23.8% in the first quarter. Fulton Bank N.A. now owns 5,100 shares of the medical instruments supplier’s stock valued at $318,000 after buying an additional 979 shares in the last quarter. Raymond James Trust N.A. raised its position in DENTSPLY SIRONA by 11.7% in the first quarter. Raymond James Trust N.A. now owns 6,031 shares of the medical instruments supplier’s stock valued at $377,000 after buying an additional 630 shares in the last quarter. Finally, Creative Planning raised its position in DENTSPLY SIRONA by 1.0% in the first quarter. Creative Planning now owns 6,800 shares of the medical instruments supplier’s stock valued at $425,000 after buying an additional 70 shares in the last quarter. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Shares of DENTSPLY SIRONA Inc. (XRAY) opened at 61.41 on Wednesday. The stock has a 50 day moving average price of $63.70 and a 200-day moving average price of $62.23. The company has a market capitalization of $14.08 billion, a price-to-earnings ratio of 39.52 and a beta of 1.26. DENTSPLY SIRONA Inc. has a one year low of $55.00 and a one year high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Tuesday, May 9th. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.50 by $0.01. The company had revenue of $900.50 million for the quarter, compared to the consensus estimate of $916.55 million. DENTSPLY SIRONA had a return on equity of 7.37% and a net margin of 9.42%. DENTSPLY SIRONA’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same period last year, the company earned $0.69 EPS. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post $2.84 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a dividend of $0.0875 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.57%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 22.58%.

TRADEMARK VIOLATION NOTICE: This report was first reported by Daily Political and is owned by of Daily Political. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/08/09/dentsply-sirona-inc-nasdaqxray-stake-reduced-by-bessemer-group-inc.html.

XRAY has been the topic of several recent analyst reports. Zacks Investment Research upgraded DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Wednesday, April 12th. Goldman Sachs Group, Inc. (The) lowered DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and reduced their target price for the stock from $60.00 to $55.00 in a report on Tuesday, May 23rd. Cleveland Research upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. BidaskClub lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, June 10th. Finally, HC Wainwright initiated coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They set a “buy” rating and a $74.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $67.92.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.